ArticlesReader.com Menu

Newest Articles
Most Viewed Articles
ArticlesReader.com RSS
Submit Article
Login
Signup

Search the articles

Articles Main Categories

Advice
Animals
Automobiles
Business
Career
Communications
Computer Programming
Computers
Entertainment
Environment
Family
Fashion
Finance
Food
Health & Medical
Home & Garden
Humor
Internet Business
Internet Marketing
Legal
Leisure & Recreation
Marketing
Other
Politics
Reference & Education
Religion
Self Improvement
Sports
Technology & Science
Travel
Writing

Subscribe

Receive alert message from us when new articles submitted to our site for free.

Syndicate

Related Products

Home::Cancer

Abdominal Chemo Increases Ovarian Cancer Survival Rate

Author : David C Skul

A large clinical test shows that giving chemotherapy directly into the stomach, as well as into a vein, can improve survival of women with advanced ovarian cancer by about sixteen months. The results of the study, which pop up in this week's issue of the New England Journal of Medicine, prompted the National Cancer Institute to issue a statement supporting doctors to employ this plan of attack for appropriate patients.

Why is this new treatment reigmine so important? Ovarian cancer is the fourth greatest reason of cancer demises in women, affecting more than 22,000 women and killing more than 16,000 in 2005. Although this disease is super treatable when saw ahead of time, virtually all cases are not noticed until they have dispersed beyond the ovaries. Because so many ovarian cancer patients are diagnosed at a later stage, it is crucial to find ways to better treatments for further progressed disease.

What is already known about ovarian cancer? virtually all women with advanced ovarian cancer get chemotherapy after surgery to get rid of the tumor. That chemotherapy is usually given into a vein and moves through the bloodstream to reach tumor cells in the stomach. Doctors have also experimented with rendering the chemotherapy straight into the abdomen through a catheter, a system called intraperitoneal (IP) chemotherapy. Eight clinical trials of this approach have been done, and most showed a gain to IP chemotherapy. But this technique is not widely wore, according to the study's author, Deborah Armstrong, MD.

"There has been a prejudice against IP therapy in ovarian cancer because it's an old idea, it requires skill and experience for the surgery and for the chemotherapy, and it's additional complicated than IV chemotherapy," said Armstrong, who is a medical oncologist and associate professor at the John Hopkins Kimmel Cancer Center in Baltimore.

How this study was done: Women with stage III ovarian cancer were randomly assigned to get either standard chemotherapy in a vein (210 women), or a combination of chemotherapy in a vein and IP chemotherapy (205 women). The women had already had surgery that successfully removed all or most of the tumor; none had tumors remaining that were larger than 1 cm in diameter. All the women were treated with the same drugs, cisplatin and paclitaxel. Six cycles of chemotherapy were planned for both groups.

What was found? Women who had IP chemo operated long without their cancer coming back and lived longest overall. Women who had traditional chemotherapy in a vein survived about 4 years after treatment, while those who got chemotherapy in the stomach as well as a vein stomach an median of nearly 5 ½ years after treatment.

That improvement is "one of the largest benefits ever observed for a new therapy in gynecologic oncology," based on data from Stephen A. Cannistra, MD, who composed an editorial published with the study. He is a professor at Harvard Medical School and managing director of the division of gynecologic medical oncology at Beth Israel Deaconess Medical Center in Boston.

Nonetheless, the IP treatment was very much more difficult on the patients. Women who had this treatment had many additional terrible or life-threatening side effects, including low white blood cell counts, infection, tiredness, and anguish. Many side effects were associated to the catheters that must be introduced into the stomach to deliver the chemotherapy. These problems were so serious that fewer than half of the women designated to undergo IP chemotherapy finished all six designed treatment cycles. That makes the survival advance that good deal supplementary noteworthy, Cannistra composed.

Women who got IP therapy also reported significantly worse caliber of life during and just after treatment. By one year out, nonetheless, both groups described similar quality of life.

Discover the best alternative cancer treatments!

SEO Solutions and one way link publicity services provided by LinkAcquire.

Article Source: http://www.articledashboard.com

David C Skul - CEO LinkAcquire.com and Relativity, Inc. can provide global market exposure and solutions.

Spam emails More free articles

More related feeds

Abdominal Chemo Increases Ovarian Cancer Survival Rate
Abdominal Chemo Increases on ovarian cancer survival RateA large clinical trial shows that giving chemotherapy directly into the stomach, and in a vein, can improve the survival of women at a stage advanced ovarian cancer by about ...

Abdominal Chemo Increases Ovarian Cancer Survival Rate
A large clinical test shows that giving chemotherapy directly into the stomach, as well as into a vein, can improve survival of women with advanced ovarian cancer by about sixteen months. The results of the study, which pop up in this ...

grade 1 ovarian cancer
The more advanced the cancer, the weaker one may be, reducing the survival rate potential. Survival rates have not changed very much over the past fifteen years. Chemotherapy can increase survival time by as much as 50 percent. ...

Zhenxiong actually a woman vicissitudes of the ovary
And by early diagnosis and treatment of patients with ovarian cancer prognosis is quite different. With epithelial ovarian cancer as an example, according to statistics, the 5-year survival rate, Ⅰ period of 80%, Ⅱ a period of 40 ...

Ovarian cancer reference
More than 50% of women with ovarian cancer are diagnosed in the advanced stages of the disease because no cost-effective screening test for ovarian cancer exists. The 5 year survival rate for all stages is only 35% to 38%. ...

Extracting cancer cells with magnetic nanoparticles
All of these issues allow tumors to grow again and increase cancer fatalities. A method of extracting residual and metastatic cancer cells could dramatically improve the long-term survival rate of patients. ...

Abdominal Chemo Increases Ovarian Cancer Survival Rate
Abdominal Chemo Increases Ovarian Cancer Survival RateA large clinical test shows that giving chemotherapy directly into the stomach, as well as into a vein, can improve survival of women with advanced ovarian cancer by about sixteen ...

Must Know Facts About Ovarian Cancer
*Fertility drugs - These may slightly increase a woman's risk to ovarian cancer. Treatment: There are various types of treatment for ovarian cancer consisting of chemotherapy, radiation therapy, and surgery. There is local therapy, ...

Will Smith th of July is my Types of chemotherapy.
She used the time between her Chemotherapy pictures treatments to tackle her painting to fill. Until we have word from the Government nothing can be taken for granted. Frequently referred to as a silent killer, ovarian cancer offers few ...

Breast Cancer
A personal history of breast cancer. If you've had breast cancer in one breast, you have an increased risk of developing cancer in the other breast. Family history. If you have a mother, sister or daughter with breast or ovarian cancer ...

Abdominal Chemo Increases Ovarian Cancer Survival Rate

Related articles